Evidence map›Paper›PMID 39693632›Full record

ArticleGigaScience2024

A dataset profiling the multiomic landscape of the prefrontal cortex in amyotrophic lateral sclerosis.

Fabian Hausmann, Lucas Caldi Gomes, Sonja Hänzelmann, Robin Khatri, Sergio Oller, Marie Gebelin, Mojan Parvaz, Laura Tzeplaeff, Laura Pasetto, Qihui Zhou and 9 more

Abstract read
In one paragraph

Article in GigaScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Fabian HausmannInstitute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neuroscience (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.ORCID 0000-0001-6110-5824
Lucas Caldi GomesTechnical University of Munich, School of Medicine, rechts der Isar Hospital, Clinical Department of Neurology, Munich 81675, Germany.ORCID 0000-0003-4959-2169
Sonja HänzelmannInstitute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neuroscience (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.ORCID 0000-0003-4953-0101
Robin KhatriInstitute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neuroscience (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.ORCID 0009-0006-5311-1718
Sergio OllerInstitute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neuroscience (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.ORCID 0000-0002-8994-1549
Marie GebelinLaboratoire de Spectrométrie de Masse Bio-Organique, Université de Strasbourg, Infrastructure Nationale de Protéomique, Strasbourg 67037, France.ORCID 0009-0001-4696-3799
Mojan ParvazTechnical University of Munich, School of Medicine, rechts der Isar Hospital, Clinical Department of Neurology, Munich 81675, Germany.ORCID 0000-0002-0644-5559
Laura TzeplaeffTechnical University of Munich, School of Medicine, rechts der Isar Hospital, Clinical Department of Neurology, Munich 81675, Germany.ORCID 0009-0003-7643-3232
Laura PasettoResearch Center for ALS, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan 20156, Italy.ORCID 0000-0003-0319-4448
Qihui ZhouGerman Center for Neurodegenerative Diseases (DZNE), Munich 81377, Germany.ORCID 0000-0001-5733-9820
Pavol ZelinaDepartment of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.ORCID 0009-0008-6776-663X
Dieter EdbauerGerman Center for Neurodegenerative Diseases (DZNE), Munich 81377, Germany.ORCID 0000-0002-7186-4653
R Jeroen PasterkampDepartment of Translational Neuroscience, University Medical Center Utrecht, Utrecht University, Utrecht 3508, The Netherlands.ORCID 0000-0003-1631-6440
Hubert RehrauerFunctional Genomics Center Zürich, ETH Zürich and University of Zürich, Zürich 8057, Switzerland.ORCID 0000-0001-7612-9394
Ralph SchlapbachFunctional Genomics Center Zürich, ETH Zürich and University of Zürich, Zürich 8057, Switzerland.ORCID 0000-0002-7488-4262
Christine CarapitoLaboratoire de Spectrométrie de Masse Bio-Organique, Université de Strasbourg , Infrastructure Nationale de Protéomique, Strasbourg 67037, France.ORCID 0000-0002-0079-319X
Valentina BonettoResearch Center for ALS, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan 20156, Italy.ORCID 0000-0003-0456-2054
Stefan BonnInstitute of Medical Systems Biology, Center for Biomedical AI (bAIome), Center for Molecular Neuroscience (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.ORCID 0000-0003-4366-5662
Paul LingorTechnical University of Munich, School of Medicine, rechts der Isar Hospital, Clinical Department of Neurology, Munich 81675, Germany.ORCID 0000-0001-9362-7096

Funding

Bundesministerium für Bildung und Forschung 01GM1917ADFG CRC1192
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, which still lacks effective disease-modifying therapies. Similar to other neurodegenerative disorders, such as Alzheimer and Parkinson disease, ALS pathology is presumed to propagate over time, originating from the motor cortex and spreading to other cortical regions. Exploring early disease stages is crucial to understand the causative molecular changes underlying the pathology. For this, we sampled human postmortem prefrontal cortex (PFC) tissue from Brodmann area 6, an area that exhibits only moderate pathology at the time of death, and performed a multiomic analysis of 51 patients with sporadic ALS and 50 control subjects. To compare sporadic disease to genetic ALS, we additionally analyzed PFC tissue from 4 transgenic ALS mouse models (C9orf72-, SOD1-, TDP-43-, and FUS-ALS) using the same methods. This multiomic data resource includes transcriptome, small RNAome, and proteome data from female and male samples, aimed at elucidating early and sex-specific ALS mechanisms, biomarkers, and drug targets.

Indexed as

Amyotrophic Lateral SclerosisPrefrontal CortexAgedAnimalsDisease Models, AnimalFemaleGene Expression ProfilingHumansMaleMiceMice, TransgenicMiddle AgedProteomeTranscriptomeProteomeamyotrophic lateral sclerosisearly disease mechanismsmultiomics analysisneurodegenerationprefrontal cortex

Identifiers

PMID39693632
PMCPMC11653894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.